Avi Oler | Senior Vice President of Corporate Development & General Counsel |
Steve Fruchtman | President & Chief Executive Officer |
Mark Gelder | Chief Medical Officer |
Mark Guerin | Chief Financial Officer |
Etzer Darout | Guggenheim Securities |
Sara Nik | H.C. Wainwright |
Robert LeBoyer | NOBLE Capital |
Ladies and gentlemen, thank you for standing by. Welcome to the Onconova Therapeutics Second Quarter 2021 Financial Results and Business Update Conference Call. At this time, all participants are in listen-only mode.
Following management’s prepared remarks, we will hold a question-and-answer session. [Operator Instructions] As a reminder, this call is being recorded today, August 12, 2021.